REG - Convatec Group PLC - Director/PDMR Shareholding

ConvaTecAnnouncement

18/03/2025 18:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250318:nRSR1936Ba&default-theme=true

RNS Number : 1936B  Convatec Group PLC  18 March 2025

18 March 2025

Convatec Group Plc

("Convatec" or "the Company")

Director/ PDMR Shareholding

The Company has been notified of the following transactions in relation to
Persons Discharging Managerial Responsibility ("PDMR") in respect of ordinary
shares of 10 pence each in the Company ("Shares").

Vesting of Awards under the Company's Long Term Incentive Plan ("LTIP")

On 14 March 2025, conditional share awards granted to Jonny Mason, Chief
Financial Officer in 2022 under the LTIP in the form of Performance Share
Awards ("PSA") vested and on 18 March 2025, shares were sold to satisfy income
tax and National Insurance ("NI") liabilities:

 Shares vested  Shares sold to satisfy income tax & NI liabilities      Share price  Total shares acquired
 516,368        239,778                                                 £2.599537    276,590

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING
MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Jonny Mason

 2    Reason for the notification

 a)   Position/status                                              Chief Financial Officer and PDMR

 b)   Initial notification /Amendment                              Initial Notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         Convatec Group Plc

 b)   LEI                                                          213800LS272L4FIDOH92

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Ordinary shares of 10p each in Convatec Group Plc

      Identification code                                          GB00BD3VFW73

 b)   Nature of the transaction                                    Vesting of PSA under the LTIP.

 c)   Price(s) and volume(s)

Price(s)  Volume(s)
                                                                   £0        516,368

 d)   Aggregated information

      - Aggregated volume                                          N/A - single transaction

      - Price

 e)   Date of the transaction                                      14 March 2025

 f)   Place of the transaction                                     Outside a trading venue

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Ordinary shares of 10p each in Convatec Group Plc

      Identification code                                          GB00BD3VFW73

 b)   Nature of the transaction                                    Immediate sale of shares awarded under the LTIP to cover tax and national

                                                            insurance liabilities.

 c)   Price(s) and volume(s)

Price(s)    Volume(s)
                                                                   £2.599537   239,778

 d)   Aggregated information

      - Aggregated volume                                          N/A - single transaction

      - Price

 e)   Date of the transaction                                      18 March 2025

 f)   Place of the transaction                                     London Stock Exchange

d)

 

Aggregated information

- Aggregated volume

N/A - single transaction

- Price

e)

 

Date of the transaction

 

14 March 2025

f)

 

Place of the transaction

 

Outside a trading venue

4

 

Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 10p each in Convatec Group Plc

Identification code

GB00BD3VFW73

b)

 

Nature of the transaction

 

 

Immediate sale of shares awarded under the LTIP to cover tax and national
insurance liabilities.

c)

Price(s) and volume(s)

 

 

 

 

 Price(s)    Volume(s)
 £2.599537   239,778

d)

 

Aggregated information

- Aggregated volume

N/A - single transaction

- Price

e)

 

Date of the transaction

 

18 March 2025

f)

 

Place of the transaction

 

London Stock Exchange

 

Enquiries

 

James Kerton Company Secretary
 

Tel: +44 (7827) 036059
Email: cosec@convatec.com

Convatec Group Plc's LEI code is 213800LS272L4FIDOH92

Classification: 2.2 Information disclosed under article 19 of the Market Abuse
Regulation

About Convatec

 

Pioneering trusted medical solutions to improve the lives we touch: Convatec
is a global medical products and technologies company, focused on solutions
for the management of chronic conditions, with leading positions in Advanced
Wound Care, Ostomy Care, Continence Care, and Infusion Care. With more than
10,000 colleagues, we provide our products and services in around 90
countries, united by a promise to be forever caring. Our solutions provide a
range of benefits, from infection prevention and protection of at-risk skin,
to improved patient outcomes and reduced care costs. Convatec's revenues in
2024 were over $2 billion. The company is a constituent of the FTSE 100 Index
(LSE:CTEC). To learn more please visit http://www.convatecgroup.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHFLFEDVIITLIE